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Summary.-A quantitative, cytochemical assay for measuring lysosomal enzymes
in the peripheral nerves of mice has been developed. That the time course of lysoso-
mal enzyme changes after misonidazole (MISO) treatment reflects the degree of
neurotoxicity of this agent in the mouse, has been confirmedbythe use of two known
neurotoxic compounds: methyl mercury and acrylamide. This effect is specific to
the peripheral nerves and was not found in liver, kidney, heart or cerebral cortex.
Enzyme activities varied with mouse strain and sex, as did the response to MISO
treatment. Ofthe mice studied, female C57 gave the greatest increase in p-glucuroni-
dase activity. With the MISO dose of 0-6 mg/g/dose the increased enzyme activity
was independent of the route of administration and appeared to approach a plateau
after 5 daily doses.
THE FACT that conventional radio-
therapy sometimes fails to eradicate some
human tumours may be due to the
presence of hypoxic, radioresistant cells.
MISO, a 2-nitroimidazole, selectively sen-
sitizes hypoxic cells, both in vitro and
in vivo, to the effect ofirradiation (Adams,
1978). Clinical trials are taking place in
several centres, but the total dose re-
quired to give full sensitization cannot be
administered, due to the side-effects of
peripheral neuropathy. The severity of
these symptoms has ranged, depending on
drug dose, from mild sensory neuro-
pathies of the hands and feet to con-
vulsions (Dische et al., 1978; Saunders
et al., 1978). Thus there is a need to
develop a less neurotoxic radiosensitizer
than MISO.
An important part of such a drug-
developmentprogrammerequires areliable
method of assessing the neurotoxicity of
radiation sensitizers in animals. The
various methods used previously to evalu-
ate MISO neurotoxicity are, however,
often difficult to interpret and evaluate
quantitatively. These have included light
and electron microscopy (Griffin et al.,
1979; Conroy et al., 1979; Adams et al.,
1980) measurements of nerve-conduction
velocity (Hirst et al., 1978, 1979; Conroy
et al., 1979, 1982; Von Burg et al., 1979)
and behavioural studies such as rotor-rod
testing (Conroy et al., 1979). There is now
a requirement for a more quantitative
assay for neurotoxicity, so that it can be
applied to the study of other known and
potentially new radiation sensitizers.
Recently, a biochemical assay has been
used to measure lysosomal enzyme activi-
ties in homogenates of peripheral nerves
of rats with two compounds of known
neurotoxicity: acrylamide and methyl
mercury (Dewar & Moffett, 1979). The
enzymes /3-glucuronidase and P-galacto-
sidase increased after treatment with
these agents, and this assay appeared to
offer a useful empirical method for
detecting chemically induced degeneration
in the peripheral nervous system. This
biochemical assay has now been applied to
the study of lysosomal enzyme activities
in the peripheral nerves of rats treated
with MISO (Rose et al., 1980); significantMISONIDAZOLE NEUROTOXICITY
increases in /3-glucuronidase and /-galacto-
sidase activities were observed.
We have applied the techniques of
quantitative cytochemistry to the study
of lysosomal enzyme activity in the
peripheral nerves of mice treated with
MISO (Clarke et al., 1980). The enzymes
P-glucuronidase and acid phosphatase
were observed to increase to a maximum
in murine peripheral nerves 3-4 weeks
after MISO treatment (0.5 mg/g i.p. daily
for 7 days) and had returned to normal
by 8 weeks, which correlated well with
behavioural studies using a simple func-
tional test. Lysosomal enzyme changes
were greater in the distal than the proxi-
mal part of the nerve, and were qualita-
tively similar to the changes observed in
chemically induced dying-back neuro-
pathies (Cavanagh, 1973; Dewar &
Moffett, 1979).
We report here the effect of different
routes ofMISO administration, drug dose,
mouse strain and sex, on the ,B-glucuroni-
dase enzyme levels in peripheral nerves.
We also report the effect of MISO on this
enzyme in other tissues, and the effect of
two compounds of known neurotoxicity,
methyl mercury and acrylamide, in peri-
pheral nerves.
MATERIALS AND METHODS
Mice.-Inbred male and female C57BL/
Cbi, WHT/Ht and CBA/Ca strains of mice
(bred within this Institute) were used.
Within each group, mice of similar weights
were used.
Dosing.-Misonidazole (MISO) was admin-
istered i.p. and i.v. in saline at 0 5 and 0f225
ml/25 g body wt respectively, and orally in
tragacanth at 0 5 ml/25 g. Acrylamide
dissolved in isotonic saline, and methyl
mercury in 4% ethanol in saline were
administered i.p. at 0 5 ml/25 g.
Preparation of the tissue sections.-The
mice were killed by cervical dislocation and
the posterior and anterior tibial nerves were
rapidly dissected; these nerves were chosen
for comparison with other published results
(Rose et al., 1980). The distal portion of the
nerve was gently packaged into a bundle
and placed in a small hole cut in the centre of
a piece of the animal's kidney (s4 x 4 mm).
This enabled easier handling of the delicate
nervous tissue by providing a supporting
structure. The nerve, supported in the
kidney tissue, was rapidly frozen to -70°C
in n-hexane (fraction from petroleum 67-
70°C, low in aromatic hydrocarbons, British
Drug Houses Ltd) in an ethanol/solid
C02 bath. Handling of the specimen was
subsequently carried out with forceps pre-
cooled with solid C02. The specimen was
removed from the hexane bath, dried
briefly on filter paper and placed in a glass
vial in a Dewar flask with solid C02. Sections,
10 jum thick, were cut with a microtome
kept at -30°C in a cryostat. The micro-
tome knife was pre-cooled to - 70°C by
packing solid C02 around the handle and
the sections removed from the knife by
apposing it to a glass slide at room tempera-
ture. The section is thus "flash-dried" over
a temperature gradient of nearly 100°C
between the glass slide and the knife. The
process of chilling and sectioning tissue has
been examined in detail by Chayen et al.
(1973) who concluded that this method of
rapidly freezing tissue and the maintenance
of very low temperatures (- 30°C to - 70°C)
minimised ice crystal formation and sub-
sequent damage to the tissue under inves-
tigation. The sections, on glass slides, were
maintained at -30°C in the cryostat until
incubation in the substrate medium at
37°C for enzyme-activity determinations.
Liver, kidney, heart and cerebral-cortex
sections were prepared similarly, except
that they did not require placing in a suppor-
tive tissue, but were frozen as small pieces
(- 4 x 4 mm) directly in the hexane bath
before sectioning.
/-Glucuronidase activity.-/3-Glucuronidase
was assayed by incubating the sections in
jars containing substrate medium, in a
water bath at 37°C for various periods. The
modified post-coupling method for /3-glu-
curonidase is explained by Chayen et al.
(1973) and yields a blue reaction product.
Quantitative measurement of enzyme reac-
tions.-The/3-glucuronidase activities in serial
tissue sections were measured by scanning
areas of 4000 /,m2 at x400 magnification,
and a wavelength of 680 nm using an M85
scanning and integrating microdensitometer
(Vickers, York). These readings, in inte-
grated optical density units, are directly
proportional to enzyme activities (Bitensky
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et al., 1973). Sections of the different tissues
were incubated in the substrate medium for
various times to determine the periods over
which the enzyme kinetics were linear. The
appropriate incubation times for the different
tissues were selected so that they fell on the
linear portions of the reaction rate curves:
60 min for nerve, heart and cerebral cortex,
45 min for liver, and 30 min for kidney
cortex. Ten areas ofeach of 2-3 sections were
measured for each specimen. The mean of
these 10 measurements was taken as the
value for the individual section. The mean
for each section gave a value for the f-
glucuronidase activity in a particular speci-
men. An additional section from each
specimen wras incubated in substrate medium
containing 9mM potassium hydrogen saccha-
rate, to inhibit the /-glucuronidase and so
detect the presence of any non-specific
coloured reaction product not due to enzyme
activity. This value was deducted from the
mean fl-glucuronidase activity for each
specimen. In practice, the values for the
inhibited sections were low and relatively
consistent. For example, the mean and the
standard error for 20 different inhibited
specimens were 13-2 + 0 7, expressed as
integrated OD units x 103.
Statistical evaluation of the measurements.-
The measurements from individual nerve
sections of different animals with and with-
out MISO (0.6 mg/g i.p., daily for 5 days)
4 weeks after commencement of treatment,
were evaluated statistically. For the control
animals, the variation between measurements
on different animals could be accounted for
by the variation in measurements on the
individual sections. The treated animals,
however, showed greater variation between
animals than could be accounted for by
variation within sections. It was therefore
considered appropriate to express the results
as means of groups of treated and untreated
animals. Groups of 5 animals were used
routinely for each treatment, and the
standard error calculated for each. For
example, a typical value for a group of
control animals is 20 + 2, and treated animals,
45+4.
RESULTS
3-Glucuronidase activity in different tissues
after MISO treatment
The 3-glucuronidase activity was
measured in various tissues of 30-50-
week-old male C57 mice after MISO
treatment (0.5 mg/g i.p., daily for 7 days).
The areas of enzyme activity in the liver,
kidney cortex, heart, cerebral cortex and
untreated peripheral nerve, divided arbi-
tarily into proximal and distal regions,
were homogenous and selected at random
for measurement. However, the areas of
activity in the treated nerves were
heterogeneous, and areas of maximum
activity were selectively measured. On
this basis no significant change in enzyme
activity was seen in tissues other than
the peripheral nerve, at 1 and 4 weeks
after the start of treatment. However,
increased activity was evident in the
nerves at 4 weeks, the activity being
greater in distal than proximal regions
(Table I).
TABLE I.-The 3-glucuronidase activity in
different tissues 1 and 4 weeks after
commencement of MISO treatment (0.5
mg/g i.p., daily for 7 days). Values are
expressed as means + s.e.
Tissue
Liver
Kidney
Heart
Cerebral cortex
Proximal nerve
Distal nerve
Controls
(saline)
84+6
50+4
18+2
16+ 1
26+2
26+2
Wreek 1
92+6
50+5
18 + 1
28+1
43+3
Week 4
71+6
48+4
17 + 1
16+ 1
37+4
57+2
This latter observation is thought to
explain the heterogeneous areas ofactivity
seen in the nerves, which necessitated the
selection of areas of activity, for the
procedure of folding the nerve in order to
embed it in kidney for sectioning results
in areas of different distal location occur-
ring in the same section. Alternative
explanations suggested to us, are that
different nerve fibres may vary in sensi-
tivity or that there may be an influx of
phagocytic mast cells.
In view of the above, further experi-
ments to investigate neurotoxicity were
performed only with the distal region of
nerves. The /-glucuronidase activity was
measured 4 weeks from the commence-
ment of MISO dosing, since peak activity
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FIG.-The effect of iniereased daily doses of
0 6 mg/g MISO on the f-glucuronidase
activity in the peripheral nerves of mice
4 weeks after commencement of treatment.
has previously been shown to occur at this
time (Clarke et al., 1980).
Effect of numbers of doses of MISO on the
/-glucuronidase activity in distal peri-
pheral nerves
The Figure shows the effect of increas-
ing the number of i.p. doses of MISO on
the /-glucuronidase activity in 8-10-
week-old female C57 mice. This activity
was significantly elevated by only a
single MISO dose of0-6 mg/g. The activity
increased with the number of daily doses,
though the rate of increase fell. In view
of this, in future work a regime of 5 daily
doses was adopted, since it would give
maximum activity with the minimum of
drug.
Variation of the route of administration of
MISO
The increase in /-glucuronidase activi-
ties at 4 weeks in the distal portions of
nerves of 8-10-week-old C57 female mice
treated with 0-6 mg/g MISO daily for
5 days, was similar whether the drug was
administered i.p. (44 +3), orally (44 + 1)
or i.v. (43 + 1). All values are given as
integrated OD units x 103 + s.e.
Effect of MISO on mice ofdifferent strains
and sexes
The P-glucuronidase activities were
similar in the untreated male and female
C57 mice, but the activities in untreated
male WHT and CBA mice were greater
than in females (Table II). In all cases,
the enzyme activities measured 4 weeks
after MISO treatment (0.6 mg/g i.p.
daily for 5 days) were greater. The per-
centage increases ranged from: 126 (WHT
Y), 138 (WHT d), 142 (CBA @) and 167
(CBA $) to 203 (C57 &) and 221 (C57 Y).
Because of the greater increase in activity
in the C57 Y mice after MISO treatment,
these animals were used for most of the
experiments in this study.
Effect of methyl mercury and acrylamide
The P-glucuronidase activity was in-
creased in peripheral nerves 4 weeks
after administration of 2 known neuro-
toxic agents, methyl mercury and acryla-
mide. Five daily doses of either methyl
mercury (7 5 x 10-3 mg/g/dose) or acry-
lamide (50 x 10-3 mg/g/dose) gave
increased 3-glucuronidase levels of 34 + 4
and 32 + 4 respectively, compared to the
control value of 18 + 2. These increases in
enzyme activity were produced by 100-
fold and 10-fold less drug, respectively,
than that of MISO used above.
DISCUSSION
The raised /3-glucuronidase activities in
TABLE II.-The effect of MISO on the P-glucuronidase activity in the peripheral nerves
of different strains and sexes of mice 4 weeks after commencement of treatment (0.6
mg/g i.p., dailyfor 5 days). Values are expressed as means + s.e.
Mouse Untreated MISO UntreatedI MISO
strains d s V y
C57 23+1 5 47+ 5 20+ 1 43 5+ 3 5
WVHT 33+1 45+ 5 26+1 5 33+ 3 5
CBA 36+ 2 52+ 8 21 5+15 36-5+ 2 5
39
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murine nerves after MISO treatment,
reported earlier (Clarke et al., 1980) and
again in this paper, appear to be specific
to peripheral nervous tissue. They were
not found in liver, kidney, heart or
cerebral cortx, examined either at the
peak time of 4 weeks after commence-
ment of treatment or at 1 week. It is of
interest that the P-glucuronidase activity
varied between the different untreated
tissues, with liver and kidney much more
active than heart, cerebral cortex and
peripheral nerves, especially when the
shorter incubation times for the first 2
tissues are taken into consideration. These
variations may well reflect the degree of
metabolic activity of the tissue examined,
with liver and kidney being more active
than heart, cerebral cortex and peripheral
nerves.
The time course ofchanges in lysosomal
enzyme activity after MISO treatment
was reflected in a behavioural study,
measuring murine gait deficiency on a
narrowing bridge (Clarke et al., 1980).
This led us to consider that the assay did
provide a measure ofneurotoxicity in the
mouse. Further support is given to this
argument from our observations, reported
here, that 2 known neurotoxic agents,
methyl mercury and acrylamide, also
raised f-glucuronidase levels. Similar
effects of these agents have been reported
in rats (Dewar & Moffett, 1979). When it
is considered that the administered doses
of these agents are of 1-2 orders of
magnitude less than our doses of MISO,
this radiosensitizer can be considered
relatively non-neurotoxic. Furthermore,
preliminary data show that methyl mer-
cury and acrylamide may produce a
greater lysosomal response before the 4-
week interval at which the effect ofMISO
is maximal. The above evidence has
established this to be a reliable method of
measuring MISO neurotoxicity, and we
have carried out a series ofexperiments to
optimize this assay. One such experiment
has shown that the mouse strain and
sex are important to the sensitivity ofthis
assay, the P-glucuronidase activity being
twice as great in untreated male CBA
mice than female C57 mice, and the
increase after MISO ranging from 26%
in female WHT to 121% in female C57.
For this reason, the latter animals were
adopted for use in subsequent experi-
ments.
This large variation in sensitivity be-
tween different mouse strains and sexes is
not perhaps unexpected. For instance,
acute LD50 values for mice have been
shown to differ by more than 70%,
depending on mouse strain and in a given
strain by more than 60% depending on
body weight (Brown et al., 1978, Dene-
kamp, personal communication). Further-
more, Conroy et al. (1982) have reported
that to achieve the same neurotoxic effect,
BALB/Cba mice require twice the neural-
tissue exposure of C3H mice. These
differences have been attributed to the
dependence ofthe pharmacology on mouse
strain and sex. It is clear that compari-
sons between the relative neurotoxicity of
different radiation sensitizers can only be
made within the same sex and strain of
mice.
The different routes of administration
studied (oral, i.p. or i.v.) did not affect the
increased ,B-glucuronidase activity from
MISO treatment (0.6 mg/g/i.p., daily for
5 days). However, 10 similar daily doses
ofMISO did not significantly increase the
P-glucuronidase activity above that after
5 doses, indicating that the effect had
reached a plateau. Therefore, at lower
doses of MISO than were used here
differences between routes of administra-
tion might occur.
In conclusion, cytochemical measure-
ment ofincreased ,B-glucuronidase activity
in distal regions of the anterior and
posterior tibial nerves has been shown to
be a method suitable for measuring the
neurotoxicity of MISO and, presumably,
other potential hypoxic cell radiosensi-
tizers. The system we have developed for
this is to administer to female C57
mice 5 daily i.p. MISO doses and to
measure the enzyme activity at 4 weeks
after the commencement of dosing.
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